West Hollywood, CACIK 20133414 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
12 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Cg Oncology Inc | 2.22M | $92.24M | 27.9% | 0 | Held |
| 2 | Rapt Therapeutics Inc | 1.56M | $52.92M | 16.0% | 0 | Held |
| 3 | Alumis Inc | 4.25M | $41.46M | 12.5% | 0 | Held |
| 4 | Centessa Pharmaceuticals PLC |
| 1.36M |
| $34.11M |
| 10.3% |
| +50.0K |
| Added |
| 5 | Verastem Inc | 3.14M | $24.20M | 7.3% | +520.0K | Added |
| 6 | Denali Therapeutics Inc | 1.00M | $16.51M | 5.0% | 0 | Held |
| 7 | Natera Inc | 67.4K | $15.43M | 4.7% | +67.4K | New |
| 8 | Agios Pharmaceuticals Inc | 530.0K | $14.43M | 4.4% | +530.0K | New |
| 9 | Kymera Therapeutics Inc | 146.3K | $11.39M | 3.4% | 0 | Held |
| 10 | Atai Life Sciences NV | 2.75M | $11.25M | 3.4% | +2.75M | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio